Francesca Ruscitti

Pharmacology And Toxicology Department Corporate Pre Clinical R&D
Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

An innovative label-free approach for investigating epithelial-mesenchymal transition: pharmacological characterization of TGF-β1 effects in A549 cells.

An innovative label-free approach for investigating epithelial-mesenchymal transition: pharmacological characterization of TGF-β1 effects in A549 cells.

Journal: Toxicology and applied pharmacology

Published: January 22, 2026

In Vivo Target Engagement Assessment of Nintedanib in a Double-Hit Bleomycin Lung Fibrosis Rat Model.

In Vivo Target Engagement Assessment of Nintedanib in a Double-Hit Bleomycin Lung Fibrosis Rat Model.

Journal: International journal of molecular sciences

Published: November 11, 2025

Investigation of Aberrant Basaloid Cells in a Rat Model of Lung Fibrosis.

Investigation of Aberrant Basaloid Cells in a Rat Model of Lung Fibrosis.

Journal: Frontiers in bioscience (Landmark edition)

Published: May 08, 2024

In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach.

In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach.

Journal: Scientific reports

Published: March 06, 2020

Modeling pulmonary fibrosis through bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation.

Modeling pulmonary fibrosis through bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: December 19, 2019

Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography.

Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography.

Journal: Frontiers in pharmacology

Published: December 03, 2019

CHF6001 Inhibits NF-κB Activation and Neutrophilic Recruitment in LPS-Induced Lung Inflammation in Mice.

CHF6001 Inhibits NF-κB Activation and Neutrophilic Recruitment in LPS-Induced Lung Inflammation in Mice.

Journal: Frontiers in pharmacology

Published: August 23, 2019

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice.

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice.

Journal: Journal of visualized experiments : JoVE

Published: May 01, 2018

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses.

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses.

Journal: Journal of visualized experiments : JoVE

Published: July 18, 2017

Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice.

Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice.

Journal: Multidisciplinary respiratory medicine

Published: December 24, 2016

Heterologous Matrix Metalloproteinase Gene Promoter Activity Allows In Vivo Real-time Imaging of Bleomycin-Induced Lung Fibrosis in Transiently Transgenized Mice.

Heterologous Matrix Metalloproteinase Gene Promoter Activity Allows In Vivo Real-time Imaging of Bleomycin-Induced Lung Fibrosis in Transiently Transgenized Mice.

Journal: Frontiers in immunology

Published: November 25, 2016

In vivo monitoring of lung inflammation in CFTR-deficient mice.

In vivo monitoring of lung inflammation in CFTR-deficient mice.

Journal: Journal of translational medicine

Published: March 01, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026